09:50 AM EST - BriaCell Therapeutics Corp. : Will present the data from biomarker analyses of its clinical trials for advanced breast cancer at the Fourth International Cancer Immunotherapy Conference as well as at The MicroCap Conference, both of which will take place in New York City. BriaCell Therapeutics Corp.
shares V.BCT are trading unchanged at $0.14.
